Tue, Jul 22, 2014, 12:37 PM EDT - U.S. Markets close in 3 hrs 23 mins


% | $
Click the to save as a favorite.

BioCryst Pharmaceuticals, Inc. Message Board

straight01shot 4 posts  |  Last Activity: Jun 9, 2014 3:02 PM Member since: May 2, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Investors not seeing their way clearly.

    by roto_hooter Jun 9, 2014 1:55 PM
    straight01shot straight01shot Jun 9, 2014 3:02 PM Flag

    Hoot: Succinct synopsis...

  • Reply to


    by huskys4u2 May 28, 2014 3:38 AM
    straight01shot straight01shot May 28, 2014 8:48 AM Flag

    See this "stabilized" 100million offering is all part of Stoney's previously announced non-dilutive financing plan... it would be a good idea to brush up your trading skills for this one... legalized stock manipulation to raise capital... sounds "bonusable" to me...

  • Reply to

    Special Bonus

    by capcod3 May 27, 2014 4:04 PM
    straight01shot straight01shot May 28, 2014 8:39 AM Flag

    Stoney must have one great agent... the guy gets a "wipe out a bevy of chimps don't leave us" non-performance bonus and then a "performance" bonus for an early clinical success... I mean isn't that his freakin' job???... What a world, what a world....

  • straight01shot by straight01shot May 25, 2014 11:30 PM Flag

    I remember a CEO giving a 4 day heads-up for releasing trial results... the real significance is not in the heads up but in the very early report... my guess is minimal activity with an expected song and dance for the long pumped Dash-2 to keep the program afloat and investors invested... if the results were outstanding why would a CEO give non-believers any chance of escape... heck no... if you're holding a fat file of great data you drop the hammer at market opening insuring maximum pain...

11.65+0.38(+3.37%)12:35 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.